Kodiak Sciences Inc

NASDAQ:KOD   4:00:00 PM EDT
5.26
-2.19 (-29.40%)
7:58:59 PM EDT: $5.30 +0.04 (+0.76%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Kodiak Sciences Inc Stock, NASDAQ:KOD

1200 Page Mill Road, Palo Alto, California 94304
United States of America
Phone: +1.650.281.0850
Number of Employees: 112

Description

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.